Reed’s, Inc. Announces Uplist to NYSE American Stock Exchange
Reed’s (OTCQX: REED) announced it expects its common stock to be approved for listing on the NYSE American and to begin trading under the symbol REED at the opening on or about November 21, 2025, subject to continued compliance with exchange rules.
The company expects OTCQX trading to continue until the close on or about November 20, 2025, after which OTCQX trading will terminate upon effectiveness of the NYSE American listing. Shareholders do not need to take any action prior to the listing.
Reed’s also expects to complete a concurrent underwritten public offering, subject to regulatory approval and market conditions, and intends to use net proceeds and existing cash to fund growth initiatives, working capital, and general corporate purposes.
Reed’s (OTCQX: REED) ha annunciato che si prevede che le sue azioni ordinarie siano ammesse alla quotazione sul NYSE American e che inizieranno a negoziarsi con il simbolo REED all'apertura del mercato il giorno 21 novembre 2025 circa, soggetto al continuo rispetto delle norme della borsa.
Si prevede che la negoziazione OTCQX continuerà fino alla chiusura del mercato circa 20 novembre 2025, dopo il quale la negoziazione OTCQX terminerà con l'efficacia della quotazione sul NYSE American. Gli azionisti non devono intraprendere azioni prima della quotazione.
Reed’s prevede anche di completare un offerta pubblica sottoscritta concorrente, soggetta all'approvazione regolamentare e alle condizioni di mercato, e intende utilizzare i proventi netti e la liquidità esistente per finanziare iniziative di crescita, capitale circolante e scopi aziendali generali.
Reed’s (OTCQX: REED) anunció que espera que sus acciones ordinarias sean aprobadas para su cotización en el NYSE American y que comiencen a negociarse bajo el símbolo REED en la apertura alrededor del 21 de noviembre de 2025, sujeto al cumplimiento continuo de las reglas de la bolsa.
La negociación en OTCQX se espera que continúe hasta el cierre alrededor del 20 de noviembre de 2025, tras lo cual la negociación en OTCQX terminará cuando entre en vigor la cotización en NYSE American. Los accionistas no necesitan tomar ninguna medida antes de la cotización.
Reed’s también espera completar una oferta pública suscrita concurrente, sujeta a aprobación regulatoria y condiciones de mercado, y tiene la intención de usar las ganancias netas y el efectivo existente para financiar iniciativas de crecimiento, capital de trabajo y fines corporativos generales.
리드(Reed’s, OTCQX: REED)는 자사 보통주가 NYSE American에 상장 승인을 받고 REED 기호로 거래를 시작할 예정이며, 거래 시작일은 대략 2025년 11월 21일경으로 규정된 거래소 규정 준수 상황에 따라 달라질 수 있다고 발표했습니다.
회사는 OTCQX 거래가 2025년 11월 20일 경까지 계속될 것으로 예상하며, 이후 NYSE American 상장 효력 발생 시 OTCQX 거래가 종료됩니다. 주주들은 상장 전에 별도의 조치를 취할 필요가 없습니다.
리드 또한 동시 배정된 공모를 규제 승인 및 시장 상황에 따라 완료할 것으로 예상하며, 순수익 및 현금을 사용해 성장 이니셔티브, 운영 자본 및 일반 기업 목적에 사용하고자 합니다.
Reed’s (OTCQX: REED) a annoncé qu'il s'attend à ce que son action ordinaire soit admise à la cotation sur le NYSE American et à commencer à être négociée sous le symbole REED à l'ouverture le 21 novembre 2025 environ, sous réserve du respect continu des règles d'échange.
La négociation OTCQX devrait se poursuivre jusqu'à la clôture autour du 20 novembre 2025, après quoi la négociation OTCQX prendra fin lors de l'efficacité de la cotation NYSE American. Les actionnaires n'ont pas besoin de prendre des mesures avant la cotation.
Reed’s prévoit également de finaliser une offre publique souscrite concurrente, sous réserve d'approbation réglementaire et de conditions de marché, et prévoit d'utiliser le produit net et la trésorerie existante pour financer des initiatives de croissance, des besoins en fonds de roulement et des finalités générales de l'entreprise.
Reed’s (OTCQX: REED) gab bekannt, dass erwartet wird, dass seine Stammaktien für die Notierung an der NYSE American zugelassen werden und unter dem Symbol REED rund um die Eröffnung am 21. November 2025 in den Handel aufgenommen werden, vorbehaltlich der fortlaufenden Einhaltung der Börsenregeln.
Es wird erwartet, dass der OTCQX-Handel bis zum Schluss um ca. 20. November 2025 andauert, woraufhin der OTCQX-Handel mit Inkrafttreten der NYSE American-Notierung endet. Aktionäre müssen vor der Notierung nichts unternehmen.
Reed’s plant außerdem, eine gleichzeitige öffentlich angebotene Aktie abzuschließen, vorbehaltlich behördlicher Genehmigungen und Marktbedingungen, und beabsichtigt, Erlöse aus Nettogewinnen und vorhandenen Barmitteln zu verwenden, um Wachstumsinitiativen, Betriebskapital und allgemeine Unternehmenszwecke zu finanzieren.
ريدز (OTCQX: REED) أعلنت أنها تتوقع أن تتم الموافقة على إدراج أسهمها العادية في NYSE American وبدء تداولها تحت الرمز REED عند الافتتاح في حوالي 21 نوفمبر 2025، رهناً بالالتزام المستمر بقواعد البورصة.
ومن المتوقع أن يستمر تداول OTCQX حتى الإغلاق في حوالي 20 نوفمبر 2025، وبعد ذلك سيتم إنهاء تداول OTCQX عند سريان إدراج NYSE American. لا يحتاج المساهمون إلى اتخاذ أي إجراء قبل الإدراج.
كما تتوقع Reed’s إكمال عرض عام موقّع متزامن، رهناً بموافقة الجهات التنظيمية وظروف السوق، وتعتزم استخدام صافي العائدات والسيولة النقدية الموجودة لتمويل مبادرات النمو ورأس المال العامل والأغراض العامة للشركة.
- Uplist to NYSE American expected on or about Nov 21, 2025
- OTCQX trading to continue through Nov 20, 2025 before delisting
- Company cites enhanced visibility and expanded investor base
- Concurrent underwritten public offering is subject to regulatory approval and market conditions
- Listing effectiveness will terminate OTCQX trading, requiring shareholders to trade on NYSE American
NORWALK, Conn., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Reed’s, Inc. (OTCQX: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, natural ginger beverages, today announced that it expects its shares of common stock to be approved for listing on the NYSE American LLC stock exchange (“NYSE American”). The Company expects that its common stock will begin trading on the NYSE American under the symbol, “REED,” at the opening of trading on or about November 21, 2025, subject to continued compliance with the exchange rules.
The Company expects that its shares of common stock will continue to trade on the OTC Markets’ OTCQX Best Market until the close of the market on or about November 20, 2025. Upon effectiveness of the listing on the NYSE American, trading of the common stock on the OTCQX will terminate. Stockholders of the Company do not need to take any action prior to the listing of the Company’s shares on the NYSE American.
“Uplisting to the NYSE American marks a significant milestone for Reed’s,” said Cyril Wallace, CEO of Reed’s. “We expect the uplisting will provide enhanced visibility and expand our investor base, while also enhancing liquidity for our shares.”
The Company expects to complete a concurrent underwritten public offering of its shares of common stock, subject to regulatory approval and market conditions. The Company intends to use the net proceeds from the offering, together with existing cash and cash equivalents, to fund growth initiatives, working capital, and other general corporate purposes.
This communication does not constitute an offer, or a solicitation of an offer, to buy or sell any securities, investment or other specific product, or a solicitation of any vote or approval, nor shall there be any sale of securities, investment or other specific product in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
About Reed's, Inc.
Reed’s is an innovative company and category leader that provides the world with high quality, premium and better-for-you beverages. Established in 1989, Reed's is a leader in craft beverages under the Reed’s®, Virgil’s® and Flying Cauldron® brand names. The Company’s beverages are now sold in over 32,000 stores nationwide.
Forward-Looking Statements
Statements in this release that are not historical facts are forward-looking statements. These forward-looking statements are typically identified by terms such as “aim,” "believe," “expect,” "look forward to,” "can," “will,” “realize,” “deliver,” and similar expressions. Forward-looking statements include, but are not limited to, statements relating to the expected uplist to the NYSE American and the timing thereof, and expectations concerning the concurrent underwritten public offering and the expected use of proceeds therefrom. These statements are subject to significant risks and uncertainties and actual results could differ materially from those projected. Reed’s cautions investors not to place undue reliance on the forward-looking statements contained in this release. These risks and uncertainties include, without limitation, risks and uncertainties related to market conditions, the risk that the Company will not be in compliance with NYSE American listing requirements, the risk that the proposed offering will not be consummated on the terms or in the amounts contemplated or otherwise and the satisfaction of customary closing conditions related to the proposed offering. Risks and uncertainties relating to Reed’s and its business can be found in the “Risk Factors” section of Reed’s annual report on Form 10-K filed on March 28, 2025, as supplemented by our quarterly report on Form 10-Q for the period ended September 30, 2025, and in the Registration Statement on Form S-1 related to the proposed offering filed with the SEC on November 12, 2025. Reed’s undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in Reed’s expectations, except as required by law.
Investor Relations Contact
Sean Mansouri, CFA or Aaron D’Souza
Elevate IR
ir@reedsinc.com
(720) 330-2829
FAQ
When will Reed’s (REED) begin trading on NYSE American?
Will Reed’s shares remain on OTCQX after the NYSE American listing?
Do Reed’s shareholders need to take action before the uplisting on Nov 21, 2025?
Is Reed’s conducting an offering alongside the uplisting and what is its purpose?
What risks could delay Reed’s (REED) uplisting or offering?
